The competing renewal of this Program Project Grant (PPG) builds on tremendous progress made by PPG investigators during the last funding cycle in defining the genotypes and phenotypes of frontotemporal lobar degeneration (FTLD). Collectively, our work has substantively redefined the neuropathology of FTLD as those with tau tangles (FTLD-Tau) and those with TDP-43 inclusions (FTLD-TDP). Moreover, genome-wide association (GWAS) studies led by PPG investigators on autopsy-confirmed FTLD-TDP as well as on autopsy-confirmed progressive supranuclear palsy (PSP) and cortical basal degeneration (CBD), subtypes of FTLD-Tau, identified additional genetic risk factors and modifiers for FTLD-TDP and FTLD-Tau, respectively. During the next funding period, PPG investigators will exploit these accomplishments by proposing a set of bold new objectives for FTLD research that will be implemented through 5 Cores and 4 Projects. Specifically, they will define clinical phenotypes of FTLD subtypes and determine if they predict cases with FTLD-Tau or FTLD-TDP, identify new FTLD mutations and conduct additional genetic studies to identify genes that modify tau pathogenicity, determine the mechanisms of tau tangle formation and evaluate genes and proteins that modify TDP-43 pathogenicity through cell culture, C. elegans and transgenic mouse models. The proposed studies will provide important insights into mechanisms of FTLD and the diagnosis and treatment of these disorders.
Successful Completions of the studies proposed in this PPG will provide better antemortem diagnosis of FTLD patients that develop tau versus TDP-43 brain pathology (FTLD-Tau versus FTLD-TDP) respectively, identify disease modifiers of tau and TDP-43 pathogenicity, and clarify disease mechanisms for TDP-43 proteinopathies and tauopathies that could improve treatment for FTLD patients.
|Irwin, David J; Xie, Sharon X; Coughlin, David et al. (2018) CSF tau and ?-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders. Neurology 90:e1038-e1046|
|Ferraro, Pilar M; Jester, Charles; Olm, Christopher A et al. (2018) Perfusion alterations converge with patterns of pathological spread in transactive response DNA-binding protein 43 proteinopathies. Neurobiol Aging 68:85-92|
|Massimo, Lauren; Xie, Sharon X; Rennert, Lior et al. (2018) Occupational attainment influences longitudinal decline in behavioral variant frontotemporal degeneration. Brain Imaging Behav :|
|Spiller, Krista J; Restrepo, Clark R; Khan, Tahiyana et al. (2018) Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy. Nat Neurosci 21:329-340|
|Rey, Nolwen L; George, Sonia; Steiner, Jennifer A et al. (2018) Spread of aggregates after olfactory bulb injection of ?-synuclein fibrils is associated with early neuronal loss and is reduced long term. Acta Neuropathol 135:65-83|
|Irwin, David J; McMillan, Corey T; Xie, Sharon X et al. (2018) Asymmetry of post-mortem neuropathology in behavioural-variant frontotemporal dementia. Brain 141:288-301|
|Lewczuk, Piotr; Riederer, Peter; O'Bryant, Sid E et al. (2018) Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. World J Biol Psychiatry 19:244-328|
|Phillips, Jeffrey S; Da Re, Fulvio; Dratch, Laynie et al. (2018) Neocortical origin and progression of gray matter atrophy in nonamnestic Alzheimer's disease. Neurobiol Aging 63:75-87|
|Kassubek, Jan; Müller, Hans-Peter; Del Tredici, Kelly et al. (2018) Longitudinal Diffusion Tensor Imaging Resembles Patterns of Pathology Progression in Behavioral Variant Frontotemporal Dementia (bvFTD). Front Aging Neurosci 10:47|
|Cousins, Katheryn A Q; Ash, Sharon; Grossman, Murray (2018) Production of verbs related to body movement in amyotrophic lateral sclerosis (ALS) and Parkinson's Disease (PD). Cortex 100:127-139|
Showing the most recent 10 out of 593 publications